| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Revenues | 377,427 | 344,334 | 329,308 | 314,393 |
| Cost of goods sold | 302,706 | 276,188 | 264,959 | 253,515 |
| Gross profit | 74,721 | 68,146 | 64,349 | 60,878 |
| Selling, general, and administrative expenses | 58,367 | 55,566 | 51,344 | 165,491 |
| Operating income (loss) | 16,354 | 12,580 | 13,005 | -104,613 |
| Interest expense | 160 | 172 | 170 | 1,026 |
| Other expense (income), net | 437 | 179 | 271 | -2 |
| Total other expenses (income) | 277 | 7 | 101 | -1,028 |
| Income (loss) before income taxes | 16,631 | 12,587 | 13,106 | -105,641 |
| Provision for income taxes | 7,038 | 3,760 | 3,833 | 176 |
| Net income (loss) | 9,593 | 8,827 | 9,273 | -105,817 |
| Less net income attributable to guardian pharmacy, llc prior to the corporate reorganization | 0 | 0 | - | 9,350 |
| Less net income (loss) attributable to non-controlling interests | -225 | -203 | -175 | 6,823 |
| Net income (loss) attributable to guardian pharmacy services, inc | 9,818 | 9,030 | 9,448 | -121,990 |
| Basic eps | - | - | 0.15 | -2 |
| Diluted eps | - | - | 0.15 | -2 |
| Basic average shares | - | - | 62,043,311 | 61,143,311 |
| Diluted average shares | - | - | 62,914,077 | 61,143,311 |
| Earnings per share, basic | 0.16 | - | - | - |
| Earnings per share, diluted | 0.15 | - | - | - |
| Weighted average number of shares outstanding, basic | 62,124,010 | - | - | - |
| Weighted average number of shares outstanding, diluted | 63,432,468 | - | - | - |
Guardian Pharmacy Services, Inc. (GRDN)
Guardian Pharmacy Services, Inc. (GRDN)